The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,2-dimethyl-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-N'-propylbutanediamide ID: ALA5287140
Max Phase: Preclinical
Molecular Formula: C25H30N4O3
Molecular Weight: 434.54
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCNC(=O)CC(C)(C)C(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2N(C)C1=O
Standard InChI: InChI=1S/C25H30N4O3/c1-5-15-26-20(30)16-25(2,3)24(32)28-22-23(31)29(4)19-14-10-9-13-18(19)21(27-22)17-11-7-6-8-12-17/h6-14,22H,5,15-16H2,1-4H3,(H,26,30)(H,28,32)/t22-/m1/s1
Standard InChI Key: PACYYBQOQIZQEP-JOCHJYFZSA-N
Molfile:
RDKit 2D
32 34 0 0 0 0 0 0 0 0999 V2000
-4.5089 0.6372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7943 1.0493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0821 0.6374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0821 -0.1876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7923 -0.5992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5089 -0.1913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4279 -0.7030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6216 -0.5127 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2681 0.2337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6355 0.9791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4397 1.1556 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6531 1.9528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0518 1.5628 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.4428 0.2337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0302 0.9483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7950 0.9483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2078 1.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0331 1.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4458 2.3777 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2711 2.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6836 3.0923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5089 3.0923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4458 0.9483 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.4428 1.6629 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6413 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0580 -2.0842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2716 -2.8787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0691 -3.0923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6509 -2.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4420 -1.7149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7950 0.1230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5097 0.5357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
7 8 2 0
9 8 1 0
10 9 1 0
3 11 1 0
11 10 1 0
11 12 1 0
10 13 2 0
9 14 1 1
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
18 23 2 0
15 24 2 0
7 25 1 0
26 25 2 0
27 26 1 0
28 27 2 0
29 28 1 0
30 29 2 0
25 30 1 0
16 31 1 0
16 32 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 434.54Molecular Weight (Monoisotopic): 434.2318AlogP: 2.89#Rotatable Bonds: 7Polar Surface Area: 90.87Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.60CX Basic pKa: 0.93CX LogP: 3.12CX LogD: 3.12Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.70Np Likeness Score: -0.34
References 1. Lee S, Love MS, Modukuri R, Chatterjee AK, Huerta L, Lawson AP, McNamara CW, Mead JR, Hedstrom L, Cuny GD.. (2023) Structure-activity relationship of BMS906024 derivatives for Cryptosporidium parvum growth inhibition., 90 [PMID:37196868 ] [10.1016/j.bmcl.2023.129328 ]